Back to the fusion: Mitofusin-2 in Alzheimer’S disease

17Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Mitochondria are dynamic organelles that undergo constant fission and fusion. Mitochondria dysfunction underlies several human disorders, including Alzheimer’s disease (AD). Preservation of mitochondrial dynamics is fundamental for regulating the organelle’s functions. Several proteins participate in the regulation of mitochondrial morphology and networks, and among these, Mitofusin 2 (Mfn2) has been extensively studied. This review focuses on the role of Mfn2 in mitochondrial dynamics and in the crosstalk between mitochondria and the endoplasmic reticulum, in particular in AD. Understanding how this protein may be related to AD pathogenesis will provide essential information for the development of therapies for diseases linked to disturbed mitochondrial dynamics, as in AD.

Cite

CITATION STYLE

APA

Sita, G., Hrelia, P., Graziosi, A., & Morroni, F. (2020, January 1). Back to the fusion: Mitofusin-2 in Alzheimer’S disease. Journal of Clinical Medicine. MDPI. https://doi.org/10.3390/jcm9010126

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free